Previous 10 | Next 10 |
Quest Diagnostics ( NYSE: DGX ) is trading 5.6% higher after it raised its guidance and beat revenue, profit estimates as its business rebounding in August and September from the softer volume trends seen earlier in the year. The company now expects 2022 ...
Quest Diagnostics ( NYSE: DGX ) is scheduled to announce Q3 earnings results on Thursday, October 20th, before market open. The consensus EPS Estimate is $2.18 (-44.9% Y/Y) and the consensus Revenue Estimate is $2.34B (-15.5% Y/Y). Over the last 2 years, DGX has beat...
Healthcare artificial intelligence company Decode Health will partner with Quest Diagnostics ( NYSE: DGX ) on using biomarker-based data to cut the time and cost of developing novel diagnostic tests and identifying new drug targets . Both companies have developed a pla...
Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics Development PR Newswire Features Nationally Scaled RNA Sequencing and Specimen Collection for Multiple Sclerosis and Non-Alcoholic Fatty Liver Disease with Plans to Ex...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list ...
Summary Guardant Health derives most of its revenue from FDA-approved liquid-biopsy services as opposed to CLIA-waived laboratory-developed tests "LDT". As the FDA prepares to extend its regulatory arm over LDT, it might be a good idea to shift your investment exposure to companie...
Quest Encourages Consumers to "Put Your ____ To The Test" in Bold and Disruptive New Ad Campaign PR Newswire SECAUCUS, N.J. , Oct. 13, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leader in diagnostic testing, unveiled a nationwide campaign, ti...
Breast and Prostate Cancer Diagnoses Still Lagging During Second Full Year of COVID-19 Pandemic, Quest Diagnostics Health Trends® Study Finds PR Newswire Analysis of more than 1.1 million test results across the United States suggests more people are living wi...
Quest Diagnostics to Acquire Outreach Lab Services Business of Summa Health PR Newswire Transaction to broaden access to innovative, quality diagnostic information services powering affordable care in Ohio SECAUCUS, N.J. , and AKRON, Ohio , O...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 PR Newswire Second quarter revenues of $2.40 billion , up 2.5% from 2023 Second quarter reported diluted earnings per share ("EPS") of $2.03 , down 1.0% from 2023; a...
BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, and Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors an...
NORTHAMPTON, MA / ACCESSWIRE / July 17, 2024 / Quest Diagnostics Today in the US, millions of women do not have access to quality maternity care during and after pregnancy, which can lead to health risks and complications for mom and baby. The Quest Diagnostics Foundation, as part of the Qu...